Li Kang Biomedical Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 2/6
Li Kang Biomedical has been growing earnings at an average annual rate of 13.4%, while the Personal Products industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 9.6% per year. Li Kang Biomedical's return on equity is 10.3%, and it has net margins of 14.7%.
Anahtar bilgiler
13.4%
Kazanç büyüme oranı
13.0%
EPS büyüme oranı
| Personal Products Sektör Büyümesi | 13.9% |
| Gelir büyüme oranı | 9.6% |
| Özkaynak getirisi | 10.3% |
| Net Marj | 14.7% |
| Son Kazanç Güncellemesi | 30 Jun 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Li Kang Biomedical (GTSM:6242) Has Some Way To Go To Become A Multi-Bagger
Apr 19
Is Li Kang Biomedical Co., Ltd. (GTSM:6242) A Smart Choice For Dividend Investors?
Mar 09Li Kang Biomedical Co., Ltd.'s (GTSM:6242) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Feb 09The Trends At Li Kang Biomedical (GTSM:6242) That You Should Know About
Jan 19We Think Li Kang Biomedical (GTSM:6242) Can Stay On Top Of Its Debt
Dec 29Three Things You Should Check Before Buying Li Kang Biomedical Co., Ltd. (GTSM:6242) For Its Dividend
Dec 08Gelir ve Gider Dağılımı
Li Kang Biomedical nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Jun 24 | 572 | 84 | 293 | 0 |
| 31 Mar 24 | 597 | 95 | 295 | 0 |
| 31 Dec 23 | 629 | 111 | 293 | 0 |
| 30 Sep 23 | 653 | 116 | 292 | 0 |
| 30 Jun 23 | 712 | 129 | 300 | 0 |
| 31 Mar 23 | 739 | 126 | 268 | 0 |
| 31 Dec 22 | 684 | 112 | 251 | 0 |
| 30 Sep 22 | 622 | 98 | 236 | 0 |
| 30 Jun 22 | 498 | 73 | 204 | 0 |
| 31 Mar 22 | 395 | 55 | 209 | 0 |
| 31 Dec 21 | 387 | 51 | 207 | 0 |
| 30 Sep 21 | 419 | 61 | 215 | 0 |
| 30 Jun 21 | 514 | 79 | 240 | 0 |
| 31 Mar 21 | 482 | 75 | 227 | 0 |
| 31 Dec 20 | 457 | 69 | 220 | 0 |
| 30 Sep 20 | 429 | 60 | 214 | 0 |
| 30 Jun 20 | 371 | 46 | 204 | 0 |
| 31 Mar 20 | 436 | 59 | 230 | 0 |
| 31 Dec 19 | 483 | 72 | 245 | 0 |
| 30 Sep 19 | 468 | 70 | 239 | 0 |
| 30 Jun 19 | 477 | 72 | 242 | 0 |
| 31 Mar 19 | 506 | 75 | 252 | 0 |
| 31 Dec 18 | 496 | 77 | 248 | 0 |
| 30 Sep 18 | 517 | 86 | 256 | 0 |
| 30 Jun 18 | 518 | 137 | 260 | 0 |
| 31 Mar 18 | 498 | 139 | 252 | 0 |
| 31 Dec 17 | 496 | 134 | 253 | 0 |
| 30 Sep 17 | 485 | 127 | 250 | 0 |
| 30 Jun 17 | 472 | 72 | 242 | 0 |
| 31 Mar 17 | 458 | 66 | 239 | 0 |
| 31 Dec 16 | 451 | 62 | 236 | 1 |
| 30 Sep 16 | 440 | 55 | 235 | 1 |
| 30 Jun 16 | 439 | 54 | 238 | 0 |
| 31 Mar 16 | 455 | 55 | 250 | 1 |
| 31 Dec 15 | 456 | 53 | 253 | 1 |
| 30 Sep 15 | 444 | 12 | 266 | 1 |
| 30 Jun 15 | 400 | 14 | 222 | 2 |
| 31 Mar 15 | 306 | -9 | 161 | 2 |
| 31 Dec 14 | 256 | -26 | 123 | 4 |
| 30 Sep 14 | 205 | -13 | 65 | 7 |
| 30 Jun 14 | 214 | -33 | 71 | 10 |
| 31 Mar 14 | 220 | -58 | 75 | 12 |
| 31 Dec 13 | 237 | -62 | 78 | 14 |
Kaliteli Kazançlar: 6242 has high quality earnings.
Büyüyen Kar Marjı: 6242's current net profit margins (14.7%) are lower than last year (18.1%).
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: 6242's earnings have grown by 13.4% per year over the past 5 years.
Büyüme Hızlandırma: 6242's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Kazançlar vs. Sektör: 6242 had negative earnings growth (-34.8%) over the past year, making it difficult to compare to the Personal Products industry average (-1%).
Özkaynak Getirisi
Yüksek ROE: 6242's Return on Equity (10.3%) is considered low.